BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH)

CUSIP: 078771300

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM NEW
Total 13F shares
1,136,514
Share change
+1,028
Total reported value
$1,399,000
Price per share
$1.23
Number of holders
17
Value change
-$56,535
Number of buys
6
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q2 2022

As of 30 Jun 2022, BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,136,514 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, BlackRock Inc., Telemetry Investments, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sepio Capital, LP, STATE STREET CORP, and Tudor Investment Corp Et Al. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.